Molecular epidemiology of HCV monoinfection and HIV/HCV coinfection in injection drug users in Liuzhou, Southern China

PLoS ONE

Volumn 3, Issue 10, 2008, Pages

  Tan, Yi ^a   Wei, Qi Hou ^b   Chen, Liu Jun ^b   Chan, Pui Chung ^a   Lai, Wen Sheng ^b   He, Ming Liang ^a   Kung, Hsiang Fu ^a   Lee, Shui Shan ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b Liuzhou Center for Disease Control and Prevention   (China)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS RNA; VIRUS DNA;

ADULT; ARTICLE; CHINA; DEMOGRAPHY; FEMALE; GENETIC DISTANCE; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTRAVENOUS DRUG ABUSE; MAJOR CLINICAL STUDY; MALE; MIXED INFECTION; MOLECULAR EPIDEMIOLOGY; NUCLEOTIDE SEQUENCE; PHYLOGENY; PREVALENCE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION; SEROLOGY; COMORBIDITY; DRUG ABUSE; DRUG USE; EPIDEMIOLOGY; GENETICS; HIGH RISK BEHAVIOR; ISOLATION AND PURIFICATION; STATISTICS; SUBSTANCE ABUSE;

HEPATITIS C VIRUS; HUMAN IMMUNODEFICIENCY VIRUS;

ADULT; CHINA; COMORBIDITY; DNA, VIRAL; DRUG USERS; EPIDEMIOLOGY, MOLECULAR; FEMALE; HEPACIVIRUS; HEPATITIS C; HIV; HIV INFECTIONS; HUMANS; MALE; NEEDLE SHARING; PREVALENCE; RISK-TAKING; SEROEPIDEMIOLOGIC STUDIES; SUBSTANCE ABUSE, INTRAVENOUS; YOUNG ADULT;

EID: 56349122830     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0003608     Document Type: Article

References (23)

1. Amini S, Ahmadi Pour MH, Azadmanesh K (2006) The phylogenetic analysis of hepatitis C virus isolates obtained from two Iranian carriers revealed evidence for a new subtype of HCV genotype 3. Virus Genes 33(3): 271-278.
2. Uusküla A, Kals M, Rajaleid K, Abel K, Talu A, et al. (2008) High-prevalence and high-estimated incidence of HIV infection among new injecting drug users in Estonia: need for large scale prevention programs. J Public Health (Oxf) 30(2): 119-125.
3. Todd CS, Abed AM, Strathdee SA, Scott PT, Botros BA, et al. (2007) HIV, hepatitis C, and hepatitis B infections and associated risk behavior in injection drug users, Kabul, Afghanistan. Emerg Infect Dis 13(9): 1327-1331.
4. Garten RJ, Zhang J, Lai S, Liu W, Chen J, et al. (2005) Coinfection with HIV and hepatitis C virus among injection drug users in southern China. Clin Infect Dis 41: Suppl 1: S18-24.
5. Lu L, Nakano T, He Y, Fu Y, Hagedorn CH, et al. (2005) Hepatitis C virus genotype distribution in China: predominance of closely related subtype 1b isolates and existence of new genotype 6 variants. J Med Virol 75(4): 538-549.
6. Djebbi A, Mejri S, Thiers V, Triki H (2004) Phylogenetic analysis of hepatitis C virus isolates from Tunisian patients. Eur J Epidemiol 19(6): 555-562.
7. Noppornpanth S, Lien TX, Poovorawan Y, Smits SL, Osterhaus AD, et al. (2006) Identification of a naturally occurring recombinant genotype 2/6 hepatitis C virus. J Virol 80(15): 7569-7577.
8. Murphy DG, Willems B, Deschênes M, Hilzenrat N, Mousseau R, et al. (2007) Use of sequence analysis of the NS5B region for routine genotyping of hepatitis C virus with reference to C/E1 and 5′ untranslated region sequences. J Clin Microbiol 45(4): 1102-1112.
9. Noppornpanth S, Smits SL, Lien TX, Poovorawan Y, Osterhaus AD, et al. (2007) Characterization of hepatitis C virus deletion mutants circulating in chronically infected patients. J Virol 81(22): 12496-12503.
10. Franco S, Tural C, Clotet B, Martínez MA (2007) Complete nucleotide sequence of genotype 4 hepatitis C viruses isolated from patients co-infected with human immunodeficiency virus type 1. Virus Res 123(2): 161-169.
11. Cantaloube JF, Laperche S, Gallian P, Bouchardeau F, de Lamballerie X, et al. (2006) Analysis of the 5′ noncoding region versus the NS5b region in genotyping hepatitis C virus isolates from blood donors in France. J Clin Microbiol 44(6): 2051-2056.
12. Kurbanov F, Tanaka Y, Sugauchi F, Kato H, Ruzibakiev R, Zalyalieva M, et al. (2003) Hepatitis C virus molecular epidemiology in Uzbekistan. J Med Virol 69(3): 367-375.
13. Alter MJ (1999) Hepatitis C virus infection in the United States. J Hepatol 31 Suppl 1: 88-91.
14. Lee DS, Sung YC, Whang YS (1996) Distribution of HCV genotypes among blood donors, patients with chronic liver disease, hepatocellular carcinoma, and patients on maintenance hemodialysis in Korea. J Med Virol 49(1): 55-60.
15. Du WJ, Xiang YT, Wang ZM, Chi Y, Zheng Y, et al. (2008) Socio-demographic and clinical characteristics of 3129 heroin users in the first methadone maintenance treatment clinic in China. Drug Alcohol Depend 94(1-3): 158-164.
16. Cantaloube JF, Gallian P, Attoui H, Biagini P, De Micco P, et al. (2005) Genotype distribution and molecular epidemiology of hepatitis C virus in blood donors from southeast France. J Clin Microbiol 43(8): 3624-3629.
17. Nakano T, Lu L, He Y, Fu Y, Robertson BH, et al. (2006) Population genetic history of hepatitis C virus 1b infection in China. J Gen Virol 87(Pt 1): 73-82.
18. Pybus OG, Charleston MA, Gupta S, Rambaut A, Holmes EC, et al. (2001) The epidemic behavior of the hepatitis C virus. Science 292(5525): 2323-5.
19. Smith DB, Pathirana S, Davidson F, Lawlor E, Power J, et al. (1997) The origin of hepatitis C virus genotypes. J Gen Virol 78(Pt 2): 321-328.
20. Candotti D, Temple J, Sarkodie F, Allain JP (2003) Frequent recovery and broad genotype 2 diversity characterize hepatitis C virus infection in Ghana, West Africa. J Virol 77(14): 7914-7923.
21. Robertson B, Myers G, Howard C, Brettin T, Bukh J, et al. (1998) Classification, nomenclature, and database development for hepatitis C virus (HCV) and related viruses: proposals for standardization. International Committee on Virus Taxonomy. Arch Virol 143(12): 2493-2503.
22. Lee KC, Lim WW, Lee SS (2008) High prevalence of HCV in a cohort of injectors on methadone substitution treatment. J Clin Virol 41(4): 297-300.
23. Ruxrungtham K, Phanuphak P (2001) Update on HIV/AIDS in Thailand. J Med Assoc Thai 84 Suppl 1: S1-17.